Correction: This story has been modified from its original version. — This article has been modified from its original version to accurately reflect the location of this year's Mid-Atlantic Biotech Conference.The Collegiate Times regrets this error.
Three local companies have made it to a prestigious biotechnology conference in the nation’s capital.
Intrexon, BC Genesis and Synthonics, all from Blacksburg, were selected to be company presenters at the 2009 Mid-Atlantic Biotech Conference at the North Maryland Conference Center in Washington, D.C.
The event, which lasted from Nov. 4-6, featured more than 850 top bioscience leaders and investors from 30 states and 10 countries.
The year’s conference featured a healthcare policy panel that provided conference attendees with “insider information” to help adapt to upcoming possible federal health reform legislation and how to benefit from federal stimulus funds.
Howard Dean addressed the conference to explain how healthcare reform would affect the biotechnology industry.
Randal Kirk, the CEO of Intrexon, was featured as a plenary speaker at the conference. Kirk received his bachelor’s at Radford University and his juris doctorate from the University of Virginia.
Sponsors of the conference, specifically from the research and university package, include Tech along with other Virginia universities such as George Mason University, UVa, James Madison University and Old Dominion University.
Leave a comment 0 Comments Write a letter to the editor
All letters to the editor must include a name, e-mail, daytime phone number and affiliation to Virginia Tech. Affiliation includes: year and major for students; position and department for faculty and staff; current city for alumni and parents.